It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
BK type Ca2+-activated K+ channels activate in response to both voltage and Ca2+. The membrane-spanning voltage sensor domain (VSD) activation and Ca2+ binding to the cytosolic tail domain (CTD) open the pore across the membrane, but the mechanisms that couple VSD activation and Ca2+ binding to pore opening are not clear. Here we show that a compound, BC5, identified from in silico screening, interacts with the CTD-VSD interface and specifically modulates the Ca2+ dependent activation mechanism. BC5 activates the channel in the absence of Ca2+ binding but Ca2+ binding inhibits BC5 effects. Thus, BC5 perturbs a pathway that couples Ca2+ binding to pore opening to allosterically affect both, which is further supported by atomistic simulations and mutagenesis. The results suggest that the CTD-VSD interaction makes a major contribution to the mechanism of Ca2+ dependent activation and is an important site for allosteric agonists to modulate BK channel activation.
Ca2+ activated BK channels are important for neural and muscle function. Here authors use a compound, BC5, to show that the interface between the cytosolic and voltage sensing domains is a major allosteric pathway for Ca2+ binding to open the channel.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Washington University, Department of Biomedical Engineering, Center for the Investigation of Membrane Excitability Disorders, Cardiac Bioelectricity and Arrhythmia Center, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002)
2 University of Missouri – Columbia, Dalton Cardiovascular Research Center, Columbia, USA (GRID:grid.134936.a) (ISNI:0000 0001 2162 3504); University of Missouri – Columbia, Department of Physics and Astronomy, Columbia, USA (GRID:grid.134936.a) (ISNI:0000 0001 2162 3504); University of Missouri – Columbia, Department of Biochemistry, Columbia, USA (GRID:grid.134936.a) (ISNI:0000 0001 2162 3504); University of Missouri – Columbia, Institute for Data Science and Informatics, Columbia, USA (GRID:grid.134936.a) (ISNI:0000 0001 2162 3504)
3 University of Massachusetts, Department of Chemistry, Amherst, USA (GRID:grid.266683.f) (ISNI:0000 0001 2166 5835); University of Massachusetts, Department of Biochemistry and Molecular Biology, Amherst, USA (GRID:grid.266683.f) (ISNI:0000 0001 2166 5835)
4 University of Miami Miller School of Medicine, Department of Physiology and Biophysics, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606)